Stockscreener 앱 받기
9.32
4.48%
0.40
시간 외 거래:
9.33
0.010
+0.11%
전일 마감가:
$8.92
열려 있는:
$9.01
하루 거래량:
9,263
Relative Volume:
0.50
시가총액:
$49.19M
수익:
-
순이익/손실:
$-71.07M
주가수익비율:
-19.02
EPS:
-0.49
순현금흐름:
$-63.98M
1주 성능:
+7.50%
1개월 성능:
+20.73%
6개월 성능:
-26.27%
1년 성능:
+54.05%
1일 변동 폭
$9.01
$9.4628
1주일 범위
$8.50
$9.5799
52주 변동 폭
$4.2701
$19.00
바이케리어스 서지컬 Stock (RBOT) Company Profile
명칭
Vicarious Surgical Inc
전화
(617) 868-1700
주소
78 FOURTH AVENUE, WALTHAM
RBOT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
9.32 | 52.68M | 0 | -71.07M | -63.98M | -0.49 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
바이케리어스 서지컬 Stock (RBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | 개시 | Credit Suisse | Outperform |
| 2021-12-07 | 개시 | Cowen | Outperform |
| 2021-11-05 | 개시 | Canaccord Genuity | Buy |
| 2021-10-18 | 개시 | BTIG Research | Buy |
| 2021-10-07 | 개시 | Piper Sandler | Overweight |
모두보기
바이케리어스 서지컬 주식(RBOT)의 최신 뉴스
What institutional flow reveals about Vicarious Surgical Inc.Neural Model for Stock Price Movement - Newser
What MACD and RSI say about Vicarious Surgical Inc.Momentum Trading Guide with Safety Limits - Newser
Will Vicarious Surgical Inc. Equity Warrant outperform the marketFree Safe Entry Stock Watch Suggestions - Newser
Using economic indicators to assess Vicarious Surgical Inc. potentialDaily Market Momentum and Pressure Analysis - Newser
Does Vicarious Surgical Inc. fit your quant trading modelFree Investment Plan With Growth Optimization - Newser
Live market analysis of Vicarious Surgical Inc.Daily Market Momentum and Pressure Analysis - Newser
What analysts say about Vicarious Surgical Inc. Equity Warrant stock outlookConsistent Gain Plan with AI Support - Newser
What does recent volatility data suggest for Vicarious Surgical Inc.Asset Growth Pattern and Return Summary - Newser
Trend Dashboard Flags Vicarious Surgical Inc. As Potential Swing TradeConservative Long Term Growth Plans Under Review - beatles.ru
Vicarious Surgical (RBOT) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Price action breakdown for Vicarious Surgical Inc.Momentum Entry Alerts with Risk Control - Newser
Will a bounce in Vicarious Surgical Inc. Equity Warrant offer an exitTechnical Setup Guide for Daily Watchlist - Newser
Vicarious Surgical Inc expected to post a loss of $2.50 a shareEarnings Preview - TradingView
How Vicarious Surgical Inc. stock performs during market volatilityFree Scalable Portfolio Growth Suggestions - Newser
Tick level data insight on Vicarious Surgical Inc. volatilityIntraday Strategy with Real Time Monitoring - Newser
Is Vicarious Surgical Inc. Equity Warrant forming a bottoming baseInvestment Timing Strategy with Market Filters - Newser
Price momentum metrics for Vicarious Surgical Inc. Equity Warrant explainedFree Stock Market Watch With Alerts - Newser
Vicarious Surgical (NYSE:RBOT) vs. LivaNova (NASDAQ:LIVN) Head to Head Contrast - Defense World
Vicarious Surgical Inc. stock retracement – recovery analysisWeekly Portfolio Update with ROI Focus - Newser
Is this a good reentry point in Vicarious Surgical Inc. Equity WarrantFree Chart Alert System With Entry Targets - Newser
Vicarious Surgical Hires Stephen From as CEO - Medical Product Outsourcing
When is Vicarious Surgical Inc. stock expected to show significant growthMarket-beating returns - Jammu Links News
Is Vicarious Surgical Inc. Equity Warrant stock entering bullish territoryOversold Opportunity Scanner with RSI Data - Newser
Why Vicarious Surgical Inc. Equity Warrant stock attracts strong analyst attentionGrowth Projection Summary for Long-Term Investors - Newser
Custom strategy builders for tracking Vicarious Surgical Inc. Equity WarrantFree Consistent Gain Investment Strategies - Newser
What analysts say about Vicarious Surgical Inc. Equity Warrant stockFree Stock Market Real-Time Monitoring - Jammu Links News
When is Vicarious Surgical Inc. Equity Warrant stock expected to show significant growthMarket-beating returns - Jammu Links News
What are analysts’ price targets for Vicarious Surgical Inc. in the next 12 monthsMarket-crushing stock picks - Jammu Links News
Vicarious Surgical Appoints Stephen From as CEO, Adam Sachs Transitions to President - AInvest
Is Vicarious Surgical Inc. a good long term investmentFree Stock Selection - Jammu Links News
Vicarious Surgical Inc. Stock Analysis and ForecastGet alerts on high-potential stock breakouts - Jammu Links News
Does Vicarious Surgical Inc. Equity Warrant stock perform well during market downturns - Jammu Links News
Is Vicarious Surgical Inc. Equity Warrant stock overvalued or undervaluedCapitalize on emerging investment opportunities - Jammu Links News
What is Vicarious Surgical Inc. company’s growth strategyAchieve impressive returns with smart timing - Jammu Links News
Why is Vicarious Surgical Inc. stock attracting strong analyst attentionBuild a portfolio that outperforms the market - Jammu Links News
What is the dividend policy of Vicarious Surgical Inc. stockBuild wealth faster with consistent growth stocks - Jammu Links News
Published on: 2025-08-04 00:10:15 - Jammu Links News
How does Vicarious Surgical Inc. compare to its industry peersUnlock hidden market opportunities today - Jammu Links News
What is Vicarious Surgical Inc. Equity Warrant company’s growth strategyCapitalize on fast-moving trading opportunities - Jammu Links News
How volatile is Vicarious Surgical Inc. Equity Warrant stock compared to the marketFree Real-Time Stock Data - Jammu Links News
How does Vicarious Surgical Inc. Equity Warrant generate profit in a changing economyMaximize portfolio growth with professional advice - Jammu Links News
Should I hold or sell Vicarious Surgical Inc. Equity Warrant stock in 2025Unlock exclusive trading strategies for gains - Jammu Links News
What makes Vicarious Surgical Inc. Equity Warrant stock price move sharplyAchieve consistent double-digit returns - Jammu Links News
Is Vicarious Surgical Inc. stock overvalued or undervaluedUnlock powerful trading techniques - Jammu Links News
What institutional investors are buying Vicarious Surgical Inc. stockUnlock powerful portfolio optimization tools - Jammu Links News
What makes Vicarious Surgical Inc. stock price move sharplyMaximize returns with strategic portfolio planning - Jammu Links News
What are Vicarious Surgical Inc. company’s key revenue driversExceptional market performance - Jammu Links News
What to expect from Vicarious Surgical Inc. in the next 30 daysFree Capital Protection Trading Strategies - Newser
What does recent volatility data suggest for Vicarious Surgical Inc. Equity WarrantHigh Yield Watchlist with Filtered Picks - Newser
Vicarious Surgical Inc. stock trendline breakdownMinimal Risk Growth Investment Opportunity Analysis - Newser
Vicarious Surgical names Stephen From as next CEO - MedTech Dive
바이케리어스 서지컬 (RBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):